Effect of budesonide inhalation combined with azithromycin in treatment of children with mycoplasma pneumonia and nursing
10.3760/cma.j.issn.1672-7088.2011.35.063
- VernacularTitle:布地奈德雾化吸入联合阿奇霉素治疗小儿支原体肺炎的疗效观察及护理
- Author:
Jie HAO
;
Xiaojun TIAN
- Publication Type:Journal Article
- Keywords:
Clinical nursing pathway;
Mycoplasma pneumoniae;
Budesonide;
Azithromycin
- From:
Chinese Journal of Practical Nursing
2011;27(35):34-35
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of budesonide inhalation combined with azithromycin in treatment of children with mycoplasma pneumonia and the corresponding clinical nursing pathway.Methods From February 2010 to 2011,100 cases of children patients with mycoplasma pneumonia (all with budesonide inhalation combined with azithromycin) were randomly divided into the experimental group and the control group with 50 patients in each group.The experimental group adopted clinical nursing pathway,while the control group underwent routine care.After one or three-month follow-up,forced vital capacity (FVC),forced vital capacity 1s (FEV1),peak expiratory flow values (PEF) and other pulmonary functional indexes and clinical efficacy were compared between two groups.Results The clinical effective rate of the experimental group was 94％,higher than the control group.FVC,FEV1,PEF changes in the experimental group were better than the control group.Conclusions Budesonide inhalation combined with azithromycin in treatment of mycoplasma pneumonia in children has good effect,coupled with the clinical nursing pathway can effectively improve lung function,reduce the incidence of adverse reactions during treatment,significantly improve the prognosis,should be used widely in clinic.
